(Q35779301)

10 August 2017

1 reference

title

Emerging drugs for endometriosis. (English)

1 reference

10 August 2017

1 reference

Luigi Fedele

1 reference

10 August 2017

Nicola Berlanda

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Expert Opinion on Emerging Drugs

10 August 2017

published in

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

167-177

1 reference

Limited hormonal responsiveness of ectopic endometrium: histologic correlation with intrauterine endometrium

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Endometriosis--a disease because it is characterized by bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Hysterectomy in the United States, 1988-1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Epidemiology of endometriosis among parous women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

The relation of endometriosis to menstrual characteristics, smoking, and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

The morphologic effect of short-term medical therapy of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Surgical treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Progestogens for endometriosis: forward to the past

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Changes in quality of life after hormonal treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Progestins for symptomatic endometriosis: a critical analysis of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Add-back therapy: extending safety and efficacy of GnRH analogues in the gynecologic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Use of aromatase inhibitors in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Role of aromatase inhibitors in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Modern medical management of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Gonadotropin-releasing-hormone-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Pathophysiology. The biologic principles of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Treating endometriosis as an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Endometriosis: abnormal endometrium and dysfunctional immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Genetics of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

Serum dioxin concentrations and endometriosis: a cohort study in Seveso, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.9.1.167

21 January 2018

Identifiers

DOI

10.1517/14728214.9.1.167

1 reference

10 August 2017

1 reference